Swipe the table sideways for more columns.

TrialConditionsStatusPhaseUpdatedMore infoNCT ID
Phase 3 Trial Evaluating the Safety & Efficacy of IMNN-001 Administered in Combination w/ Standard NACT & Adjuvant Chemotherapy in Newly Diagnosed Patients w/ Advanced EOC, Fallopian Tube or Primary Peritoneal CancerAdnexal Diseases, Carcinoma, Ovarian Epithelial, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Genital Diseases, Neoplasms by Histologic Type, Neoplasms by Site, Urogenital Diseases, Urogenital Neoplasms, carcinoma, endocrine system disorder, epithelial neoplasm, fallopian tube cancer, fallopian tube disorder, fallopian tube neoplasm, female reproductive system disorder, female reproductive system neoplasm, gonadal disorder, malignant endocrine neoplasm, neoplasm, ovarian cancer, ovarian disorder, primary peritoneal carcinomaRecruitingPhase 32026-10-05NCT06915025

1 results · Page 1 of 1

Swipe the table sideways for more columns.

OrganizationsLinked trials
Imunon3

9 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sitesCityCountryLinked trials
Advent HealthOrlandoUnited States15
Erlanger HealthChattanoogaUnited States5
Froedtert and The Medical College of WisconsinMilwaukeeUnited States21
Louisiana State University HSC - NO Cancer CenterNew OrleansUnited States1
Masonic Cancer Center, University of MinnesotaMinneapolisUnited States15
Providence Cancer InstitutePortlandUnited States17
Providence Sacred Heart Medical Center & Children's HospitalSpokaneUnited States4
Sanford HealthSioux FallsUnited States14
Washington University School of Medicine in St. LouisSt LouisUnited States31